Skip to content
harmaline
EntityQ135270· pop 17· linked from 1,110 articles

Also known as 7-methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole

Harmaline, also known as 7-methoxyharmalan or as 3,4-dihydro-7-methoxy-1-methyl-β-carboline, is a harmala alkaloid and β-carboline which has hallucinogenic effects and monoamine oxidase inhibitor (MAOI) activity. It is the partly hydrogenated form of harmine.

~9 min read

Encyclopedic overview

20 sections
Contents
  • Use and effects
  • As a hallucinogen
  • As an MAOI
  • Interactions
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Chemistry
  • Properties
  • Synthesis
  • Analogues
  • Natural occurrence
  • History
  • Society and culture
  • Legal status
  • Australia
  • Canada
  • See also
  • References
  • External links

Harmaline, also known as 7-methoxyharmalan or as 3,4-dihydro-7-methoxy-1-methyl-β-carboline, is a harmala alkaloid and β-carboline which has hallucinogenic effects and monoamine oxidase inhibitor (MAOI) activity. It is the partly hydrogenated form of harmine.

Plants containing harmaline are combined in ayahuasca to inhibit monoamine oxidase, allowing orally consumed dimethyltryptamine (DMT) to become orally active and produce psychoactive effects. Harmala alkaloids, including harmaline, are psychoactive on their own in humans, with harmaline being particularly hallucinogenic, although other compounds such as harmine and tetrahydroharmine have also been reported to produce hallucinogenic effects as well.

Excerpted from Wikipedia’s “harmaline” article, available under the CC BY-SA 4.0 licence.

Gallery (2)